Wanbury’s subsidiary files petition for voluntary insolvency

08 Nov 2013 Evaluate

Wanbury’s subsidiary - Cantabria Pharma S.L., Spain, has filed petition for voluntary insolvency in the Commercial Courts of Madrid, Spain on November 04, 2013.

Wanbury’s major thrust area lies in Active Pharmaceutical Ingredient (API) and Contract Research and Manufacturing Services (CRAMS). It has a presence in Spain through its branded formulation business - Cantabria Pharma S. L acquired in 2006.

Wanbury Share Price

210.20 6.30 (3.09%)
13-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1683.85
Dr. Reddys Lab 1107.85
Cipla 1461.60
Lupin 1969.05
Zydus Lifesciences 882.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...